» Articles » PMID: 29560920

Distinct Neural-Functional Effects of Treatments With Selective Serotonin Reuptake Inhibitors, Electroconvulsive Therapy, and Transcranial Magnetic Stimulation and Their Relations to Regional Brain Function in Major Depression: A Meta-analysis

Overview
Date 2018 Mar 22
PMID 29560920
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Functional neuroimaging studies have examined the neural substrates of treatments for major depressive disorder (MDD). Low sample size and methodological heterogeneity, however, undermine the generalizability of findings from individual studies. We conducted a meta-analysis to identify reliable neural changes resulting from different modes of treatment for MDD and compared them with each other and with reliable neural functional abnormalities observed in depressed versus control samples.

Methods: We conducted a meta-analysis of studies reporting changes in brain activity (e.g., as indexed by positron emission tomography) following treatments with selective serotonin reuptake inhibitors (SSRIs), electroconvulsive therapy (ECT), or transcranial magnetic stimulation. Additionally, we examined the statistical reliability of overlap among thresholded meta-analytic SSRI, ECT, and transcranial magnetic stimulation maps as well as a map of abnormal neural function in MDD.

Results: Our meta-analysis revealed that 1) SSRIs decrease activity in the anterior insula, 2) ECT decreases activity in central nodes of the default mode network, 3) transcranial magnetic stimulation does not result in reliable neural changes, and 4) regional effects of these modes of treatment do not significantly overlap with each other or with regions showing reliable functional abnormality in MDD.

Conclusions: SSRIs and ECT produce neurally distinct effects relative to each other and to the functional abnormalities implicated in depression. These treatments therefore may exert antidepressant effects by diminishing neural functions not implicated in depression but that nonetheless impact mood. We discuss how the distinct neural changes resulting from SSRIs and ECT can account for both treatment effects and side effects from these therapies as well as how to individualize these treatments.

Citing Articles

Convergent functional effects of antidepressants in major depressive disorder: a neuroimaging meta-analysis.

Saberi A, Ebneabbasi A, Rahimi S, Sarebannejad S, Sen Z, Graf H Mol Psychiatry. 2024; 30(2):736-751.

PMID: 39406999 PMC: 11746144. DOI: 10.1038/s41380-024-02780-6.


The association of posttraumatic stress disorder, depression, and head injury with mid-life cognitive function in civilian women.

Lawn R, Jha S, Liu J, Sampson L, Murchland A, Sumner J Depress Anxiety. 2021; 39(3):220-232.

PMID: 34970809 PMC: 8901526. DOI: 10.1002/da.23233.


Neural Responses to Fluoxetine in Youths with Disruptive Behavior and Trauma Exposure: A Pilot Study.

Hwang S, Chung U, Chang Y, Kim E, Suk J, Meffert H J Child Adolesc Psychopharmacol. 2021; 31(8):562-571.

PMID: 34076503 PMC: 8575058. DOI: 10.1089/cap.2020.0174.


The Application of a Machine Learning-Based Brain Magnetic Resonance Imaging Approach in Major Depression.

Na K, Kim Y Adv Exp Med Biol. 2021; 1305:57-69.

PMID: 33834394 DOI: 10.1007/978-981-33-6044-0_4.


Electroconvulsive Therapy Modulates Resting-State EEG Oscillatory Pattern and Phase Synchronization in Nodes of the Default Mode Network in Patients With Depressive Disorder.

Takamiya A, Hirano J, Yamagata B, Takei S, Kishimoto T, Mimura M Front Hum Neurosci. 2019; 13:1.

PMID: 30774588 PMC: 6367251. DOI: 10.3389/fnhum.2019.00001.